EVPL and chronic myelogenous leukemia, BCR-ABL1 positive: Specifically, curcumin downregulated the p210 BCR‐ABL fusion protein—a hallmark of CML—and suppressed downstream signaling proteins such as MEK‐1 and c‐JUN, effectively impairing leukemic cell survival.